Process analytical technology tools for process control of roller compaction in solid pharmaceuticals manufacturing by Vovko Aleša Dular, Vrečer Franc

Get full text

Controlling shareholders’ equity pledge and corporate innovation investment—empirical analysis based on pharmaceutical manufacturing by Jiawen Li, Xingyu Zhao, Su Wang, Su Wang, Yuwen Chen, Yuwen Chen

Subjects: Get full text

Evaluation of Prediction Models for the Capping and Breaking Force of Tablets Using Machine Learning Tools in Wet Granulation Commercial-Scale Pharmaceutical Manufacturing by Sun Ho Kim, Su Hyeon Han, Dong-Wan Seo, Myung Joo Kang

Get full text

The impact of the centralized volume-based procurement policy on Chinese pharmaceutical manufacturing firms' R&D investment: A difference-in-differences approach. by Fangjun Qiu, Shouming Chen, Yujia Li, Xianjing Wang, Mengfei Zhu

“…Drawing data from listed manufacturing firms in China's A-share market (2015-2020), the results from a difference-in-differences analysis with different model specifications indicate that the CVBP significantly promotes the pharmaceutical manufacturing firms' R&D investment. Moreover, the positive effect of the CVBP on R&D investment is stronger in pharmaceutical manufacturing firms with high marketing expenses. …”
Get full text

Crystal structure of 14-(R)-(2′-cyano-phenoxy)-3,19-diacetyl andrographolide, C31H37NO7 by Liu Zhuyun, Ding Pengfei, Yang Shanshan, Zhai Donghua, Sha Yunying, Zhang Ruifang, Wang Lizhong

Get full text

Rapid Characterization of Tanshinone Extract Powder by Near Infrared Spectroscopy by Gan Luo, Bing Xu, Xinyuan Shi, Jianyu Li, Shengyun Dai, Yanjiang Qiao

“…The active pharmaceutical ingredients have a direct impact on the herbal extract’s efficacy, while the physical properties of raw material affect the pharmaceutical manufacturing process and the final products’ quality. …”
Get full text

Effect of Geometry on the Dissolution Behaviour of Complex Additively Manufactured Tablets by Seyedebrahim Afkhami, Meisam Abdi, Reza Baserinia

“…Additive manufacturing (AM) processes, such as fused deposition modelling (FDM), have emerged as transformative technologies in pharmaceutical manufacturing, enabling the production of drug delivery systems with complex and customised geometries. …”
Get full text

In vitro and ex vivo models of the oral mucosa as platforms for the validation of novel drug delivery systems by Robyn A Macartney, Abijit Das, Atina G Imaniyyah, Annabelle TR Fricker, Andrew M Smith, Stefano Fedele, Ipsita Roy, Hae-Won Kim, Dongjoon Lee, Jonathan C Knowles

“…The benefit of complex 3D models to facilitate the robust testing of new drugs and drug delivery systems during the developmental stages of pharmaceutical manufacturing has recently become distinguished within the field. …”
Get full text

A novel social-network-analysis-based approach for analyzing complex network of actors involved in accessibility of anti-cancer medications in Iran by Kamran Bagheri Lankarani, Leila Zarei, Esmaeil Alinezhad, Adel Sadeghdoost

“…The computational results revealed that the Iran Food and Drug Administration (IFDA), Pharmaceutical Importer Companies (PharIc) and Pharmaceutical Manufacturing Companies (PharMC) were highly important actors in terms of their connectivity to other actors. …”
Get full text

PENGGUNAAN SARUNG TELUR MENTADAK DALAM PERUBATAN TRADISIONAL CINA MENURUT PERSPEKTIF FIQH KEPENGGUNAAN by Zubair Amir Nur Rashid, Nur Mardia Mazri

“…Standards from halal authorities such as the Department Standards of Malaysia are also reviewed for pharmaceutical manufacturing rules including the requirement of safety assessment. …”
Get full text

Price Cap Models in Pharmaceutical Online-to-Offline Supply Chains by Yi Zheng, Li Liu, Victor Shi, Bin Liu, Wenxing Huang

“…Furthermore, there are various stakeholders including pharmaceutical manufacturer, distributors, retailers, patients, and the government. …”
Get full text

Value-added service provision through ICT by drug wholesalers in Japan by Tsutomu Nakamura

“…In addition to performing intermediate distribution, they have also intensified logistics functions for pharmaceutical manufacturers and pharmacies. Because drug wholesalers need to meet the local needs of specific regions when introducing ICT, the technology is not implemented in all areas. …”
Get full text

WASTEWATER TREATMENT OF PIGMENT PRODUCTION PLANTS IN TWO STAGES: PREPARED ACTIVATED CARBON AND ELECTRODIALYSIS PROCESS by Mohammed Q. Gubari, Bilal S. Taha

“…They are widely used in dyestuff, cosmetics, food products, pharmaceuticals, manufacturing processes, etc. This study focuses on the removal of pigments and other components from wastewater discharged from pigment plants. …”
Get full text

ORAL CONTROLLED RELEASE MATRIX FORMULATION DESIGN AND THEIRRATE CONTROLLING FACTORS by Maria Ashfaq et al

“…Development of matrix-based tablets with persistent drug release has always been a challenge to the pharmaceutical manufacturers owed to various biological, physicochemical and release limiting factors. …”
Get full text

Technological Cooperation Networks at Bio-Manguinhos: the Role of Information and Communication Technologies by Lázaro Pereira de Oliveira, Claudio Pitassi, Antônio Augusto Gonçalves

“…This article identifies and discusses the contribution of information and communication technologies (ICTs) to the technological cooperation projects of Bio-Manguinhos, a pharmaceutical manufacturer that belongs to Osvaldo Cruz Foundation (FIOCRUZ), responsible for producing vaccines, reagents and biopharmaceuticals, with priority on meeting the needs of the Brazilian public health system. …”
Get full text

Institutions and Incentives in Antitrust Enforcement by Spencer Weber Waller

“…The Supreme Court followed this basic approach in Leegin, applying the rule of reason to resale price maintenance agreements (vertical price fixing), and in Actavis, applying the rule of reason to pay-for-delay agreements involving branded and generic pharmaceutical manufacturers. This essay explores where this strategy has been successful (Actavis) and where it has not (Leegin). …”
Get full text

Drug Disposal and Ecopharmacovigilance Practices in the Krowor Municipality, Ghana by Yvonne Yirenkyiwaa Esseku, Priscilla Kolibea Mante, Alex Nii Oto Dodoo, Eric Woode

“…The questionnaires were used to gather information from community members, community pharmacies, and pharmaceutical manufacturers in Krowor. Results. The drug disposal flow diagram shows that up to 96% of pharmaceuticals are handled and disposed of in ways that are harmful to the environment with only 4% being handled in ways that are environmentally friendly. …”
Get full text

Methods of forensic examination of Nalbuphine by I. О. Besedina

“…At present, in Ukraine, nalbuphine is not subject to subject-quantitative accounting in healthcare facilities and by pharmaceutical manufacturers, but in some countries it is included in the list of narcotic drugs. …”
Get full text

Effectiveness of a Patient Support Program in Supporting Access to Therapy for Solid Tumor Malignancies by Lindsay Parker, Alissa Shaul, Brian Murphy, Zeba M. Khan

“…**Background:** Certain governmental agencies, patient advocacy organizations, and pharmaceutical manufacturers have implemented programs to assist patients in overcoming barriers to accessing healthcare. …”
Get full text